Evidence map›Paper›PMID 32019112›Full record

ArticleInternational journal of molecular sciences2020

IBTK Haploinsufficiency Affects the Tumor Microenvironment of Myc-Driven Lymphoma in E-myc Mice.

Eleonora Vecchio, Giuseppe Fiume, Chiara Mignogna, Enrico Iaccino, Selena Mimmi, Domenico Maisano, Francesco Trapasso, Ileana Quinto

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Mouse Models ofFrontiers in immunology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Eleonora VecchioDepartment of Experimental and Clinical Medicine, University Magna Graecia of Catanzaro, 88100 Catanzaro, Italy.ORCID 0000-0001-8422-2679
Giuseppe FiumeDepartment of Experimental and Clinical Medicine, University Magna Graecia of Catanzaro, 88100 Catanzaro, Italy.ORCID 0000-0002-5414-6190
Chiara MignognaInterdepartmental Service Center, University "Magna Graecia" of Catanzaro Medical School, 88100 Catanzaro, Italy.ORCID 0000-0001-5576-4946
Enrico IaccinoDepartment of Experimental and Clinical Medicine, University Magna Graecia of Catanzaro, 88100 Catanzaro, Italy.ORCID 0000-0002-3565-7817
Selena MimmiDepartment of Experimental and Clinical Medicine, University Magna Graecia of Catanzaro, 88100 Catanzaro, Italy.
Domenico MaisanoDepartment of Experimental and Clinical Medicine, University Magna Graecia of Catanzaro, 88100 Catanzaro, Italy.
Francesco TrapassoDepartment of Experimental and Clinical Medicine, University Magna Graecia of Catanzaro, 88100 Catanzaro, Italy.
Ileana QuintoDepartment of Experimental and Clinical Medicine, University Magna Graecia of Catanzaro, 88100 Catanzaro, Italy.
Magna Graecia University · IT

Funding

POR FES/FESR 2014-20-ATS ALCMEONE cup 378 J18C17000610006
6 · The paper itself

Abstract

The tumor microenvironment is a dynamic and interactive supporting network of various components, including blood vessels, cytokines, chemokines, and immune cells, which sustain the tumor cell's survival and growth. Murine models of lymphoma are useful to study tumor biology, the microenvironment, and mechanisms of response to therapy. Lymphomas are heterogeneous hematologic malignancies, and the complex microenvironment from which they arise and their multifaceted genetic basis represents a challenge for the generation and use of an appropriate murine model. So, it is important to choose the correct methodology. Recently, we supported the first evidence on the pro-oncogenic action of IBTK in Myc-driven B cell lymphomagenesis in mice, inhibiting apoptosis in the pre-cancerous stage. We used the transgenic

Indexed as

HaploinsufficiencyTumor MicroenvironmentAdaptor Proteins, Signal TransducingAnimalsApoptosisB-LymphocytesCell SurvivalImmunophenotypingLoss of HeterozygosityLymphomaLymphoma, B-CellMiceMice, TransgenicNeovascularization, PathologicPrecursor Cells, B-LymphoidProto-Oncogene Proteins c-mycAdaptor Proteins, Signal TransducingIBtk protein, mouseMyc protein, mouseProto-Oncogene Proteins c-mychaploinsufficiencyheterozygous mutationIBTKlymphomaMyctumor microenvironment

Identifiers

PMID32019112
PMCPMC7038122
OpenAlexW3003254681

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.